School-Based Interventions for Anxiety in Autism
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two school-based programs to help manage anxiety in autistic students. It compares the effectiveness of the "Facing Your Fears-School Based" program, which involves learning about emotions and gradually facing fears, with the "Zones of Regulation," which teaches emotion regulation using color-coded zones. The trial seeks feedback on the effectiveness of these programs and the satisfaction levels of students, caregivers, and school providers. It invites autistic students aged 8-14 who experience anxiety to participate. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance anxiety management strategies for autistic students.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that these school-based interventions are safe for autistic students with anxiety?
Research has shown that the Facing Your Fears-School Based (FYF-SB) program is well-supported by evidence. Several studies have proven it reduces anxiety in students with autism. Past trials demonstrated its effectiveness and safety for this group.
In contrast, the Zones of Regulation (ZOR) program lacks substantial scientific evidence for use with autistic individuals. Although widely used for social-emotional skills, some reviews advise caution due to limited research confirming its effectiveness and safety for autistic students.
In summary, the FYF-SB program is backed by strong research and is generally considered safe for autistic students. The ZOR program, while popular, has less scientific support, making its safety and effectiveness for autistic students less certain.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for anxiety in autism because they offer unique, school-based approaches that differ from traditional therapy options like cognitive-behavioral therapy (CBT) or medication. "Facing Your Fears - School Based" stands out by incorporating graded exposure to fears and emotions over 12 weeks, which helps students gradually become more comfortable with their anxieties while still in their familiar school environment. On the other hand, "Zones of Regulation" introduces a creative psychoeducational approach by using colors to represent emotional states, helping students identify and regulate their emotions through practical strategies. Both programs focus on equipping students with tools for real-life situations, potentially making them more engaging and effective for young individuals with autism.
What evidence suggests that this trial's treatments could be effective for managing anxiety in autistic students?
This trial will compare the effectiveness of two programs for reducing anxiety in autistic students: Facing Your Fears-School Based (FYF-SB) and Zones of Regulation (ZOR). Research has shown that both programs can help reduce anxiety. Studies on FYF-SB, based on cognitive behavioral therapy (CBT), found that it significantly lowers anxiety levels in young participants. Evidence also supports the ZOR program, which teaches emotional control using color-coded zones and has improved emotional and behavioral outcomes in autistic students. Both programs offer structured methods to manage anxiety and enhance emotional control.23567
Who Is on the Research Team?
Judy Reaven, Ph.D.
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for autistic students aged 8-14 who experience anxiety and have a medical or educational diagnosis of ASD, or suspected ASD. They must also show significant social challenges as measured by the SRS-2. It's not suitable for those outside this age range or without these specific needs.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the Facing Your Fears-School Based Program (FYF-SB) or Zones of Regulation (ZOR) for 12 weeks
Post-Intervention Assessment
Assessments conducted to evaluate the effectiveness of the interventions
Follow-up
Participants are monitored for long-term outcomes and effectiveness of the interventions
What Are the Treatments Tested in This Trial?
Interventions
- Facing Your Fears - School Based
- Zones of Regulation
Trial Overview
The study compares two programs: Facing Your Fears-School Based (FYF-SB) and Zones of Regulation (ZOR), to see which is better at reducing anxiety and helping with emotion regulation in autistic students. Participants will be randomly assigned to one program for 12 weeks, with evaluations before, after, and following the intervention.
How Is the Trial Designed?
2
Treatment groups
Active Control
Zones of Regulation (ZOR) focuses on four different emotional states called "zones." Each zone is represented by different colors that represent different levels of emotions or arousal. ZOR includes psychoeducation about emotions and emotional states (e.g., reading facial expressions, identifying triggers for emotion dysregulations, using emotion regulation tools) and problem-solving strategies. In ZOR, students are also taught emotion regulation strategies (e.g., "calming", "cognitive" and "sensory" strategies) to stay in a specific zone and/or to move from one zone to another.
Facing Your Fears-School Based (FYF-SB) is a 12 week school based group program comprised of psychoeducation (somatic management, development of positive self-statements and strategies for managing emotions), and graded exposure (facing fears a little at a time).
Facing Your Fears - School Based is already approved in United States for the following indications:
- Anxiety management in autistic students
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
Emory University
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
University of North Carolina, Chapel Hill
Collaborator
Published Research Related to This Trial
Citations
Facing your fears in schools: using the ADIS/ASA to ... - PubMed
School-based CBT programs, like Facing Your Fears in Schools (FYF-S), have shown effectiveness in reducing anxiety in autistic students and may ...
Facing your fears in schools: using the ADIS/ASA to ...
Autistic youth are at higher risk of developing anxiety compared to their peers, with as many as 40% experiencing clinical anxiety.
Comparing the Effectiveness of Two School-Based ...
This study compares the effectiveness of two school-based programs rooted in cognitive behavioral therapy principles to reduce anxiety ...
Emotion regulation and behavior concerns
This study utilized secondary data from a cluster randomized trial evaluating the Facing Your Fears in Schools (FYF-S) program, a manualized, group-based, CBT ...
5.
medschool.cuanschutz.edu
medschool.cuanschutz.edu/jfk-partners/clinical-services/facing-your-fears-program/research--evidence-base--and-publicationsResearch, Evidence Base, and Publications
Results indicated that significant improvements in anxiety were apparent for participating youth (Solish et al. 2020). Facing Your Fears in Schools (FYF-S; ...
6.
products.brookespublishing.com
products.brookespublishing.com/Facing-Your-Fears-in-Schools-P1545.aspxFacing Your Fears in Schools
FYF is evidence based, has been shown to reduce anxiety in students with autism, and is an ideal way to increase student access to critical mental health ...
Modified School-Based Facing Your Fears for Students ...
They highlight educator's ability to deliver empirically-supported treatments to address anxiety among students with Autism Spectrum. Disorder.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.